Correlation Between Dupont De and EFFECTOR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dupont De and EFFECTOR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and EFFECTOR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and EFFECTOR Therapeutics, you can compare the effects of market volatilities on Dupont De and EFFECTOR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of EFFECTOR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and EFFECTOR Therapeutics.
Diversification Opportunities for Dupont De and EFFECTOR Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Dupont and EFFECTOR is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and EFFECTOR Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EFFECTOR Therapeutics and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with EFFECTOR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EFFECTOR Therapeutics has no effect on the direction of Dupont De i.e., Dupont De and EFFECTOR Therapeutics go up and down completely randomly.
Pair Corralation between Dupont De and EFFECTOR Therapeutics
If you would invest 6,967 in Dupont De Nemours on November 27, 2024 and sell it today you would earn a total of 1,215 from holding Dupont De Nemours or generate 17.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Dupont De Nemours vs. EFFECTOR Therapeutics
Performance |
Timeline |
Dupont De Nemours |
EFFECTOR Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Dupont De and EFFECTOR Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dupont De and EFFECTOR Therapeutics
The main advantage of trading using opposite Dupont De and EFFECTOR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, EFFECTOR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EFFECTOR Therapeutics will offset losses from the drop in EFFECTOR Therapeutics' long position.Dupont De vs. Eastman Chemical | Dupont De vs. Olin Corporation | Dupont De vs. Cabot | Dupont De vs. Kronos Worldwide |
EFFECTOR Therapeutics vs. Celularity | EFFECTOR Therapeutics vs. Humacyte | EFFECTOR Therapeutics vs. NRx Pharmaceuticals | EFFECTOR Therapeutics vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
CEOs Directory Screen CEOs from public companies around the world | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |